MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- A8254 SB 2035809 CitationTarget: p38|PKBSummary: P38 MAP kinase inhibitor
- A1632 SB202190 (FHPI)5 CitationTarget: p38Summary: P38 MAPK inhibitor
- A5566 LY22288201 CitationTarget: p38Summary: P38 MAP kinase inhibitor
- A8686 VX-745Target: p38Summary: P38α inhibitor,highly potent and selective
- A8689 PD 169316Target: p38Summary: P38 MAPK inhibitor
- B1285 SB 203580 hydrochlorideTarget: p38Summary: Specific p38-MAPKs inhibitor
- B7784 AL 8697Target: p38Summary: p38α inhibitor,potent and selective
- B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase
- A3792 SB 2390631 CitationTarget: p38Summary: P38 MAP kinase inhibitor